Physician profile
Thomas J Seales
NPI 1104184951
$131,838.92
in general payments reported to CMS, 2019-2025
16 companies · $51K in 2025
The $51K reported for 2025 was more than what 88% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $62.07 · 2021: $309 · 2022: $1,447 · 2023: $31K · 2024: $47K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $102K · Travel and Lodging: $25K · Food and Beverage: $3,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $101,700.00 |
| Travel and Lodging | $24,647.08 |
| Food and Beverage | $3,189.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $124,114.87 | 2019-2025 | Mako, Insignia, Triathlon |
| Zimmer Biomet Holdings, INC. | $5,078.79 | 2022-2024 | Rosa, Continuum, Persona |
| Medacta USA, INC. | $1,679.12 | 2025 | Gmk Sphere |
| Smith+Nephew, INC. | $149.68 | 2019-2021 | |
| Ortho Development Corporation | $141.88 | 2022 | |
| Organogenesis INC. | $133.60 | 2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Davol INC. | $120.22 | 2022 | |
| Kuros Biosciences USA, INC | $116.83 | 2023 | |
| Cgg Medical INC | $94.88 | 2023 | |
| Next Science LLC | $47.71 | 2020 | |
| Ethicon US, LLC | $46.44 | 2024-2025 | Vistaseal, Evarrest, Stratafix |
| Depuy Synthes Sales INC. | $34.33 | 2021 | |
| Biocomposites INC | $27.90 | 2024 | |
| Convatec INC. | $22.29 | 2019-2021 | |
| Si-Bone, INC. | $16.02 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $14.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Seales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.